Skip to main content

Table 2 List of included single nucleotide polymorphisms (SNPs), and their frequencies (percentages)

From: Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors

 

Genotype

Gene

n

GG

GA

AA

CC

CA

n (%)

n (%)

n (%)

n (%)

n (%)

ABCC2/MRP2rs8187710

954

842 (88.3)

110 (11.5)

2 (0.2)

  

ABCG2/BRCPrs2231137

955

888 (93.0)

67 (7.0)

   

CYP2B6rs2279343

910

57 (6.2)

382 (42.0)

471 (51.8)

  

CYP2C8rs72558196

960

  

960 (100)

  

CYP2C9rs1057910

954

  

853 (89.4)

3 (0.3)

98 (10.3)

CYP2C19rs4244285

946

652 (68.9)

266 (28.1)

28 (3.0)

  

CYP2C19rs4986893

960

960 (100)

    

CYP3A4rs2740574

955

2 (0.2)

57 (6)

896 (93.8)

  

CYP3A4rs55785340

957

  

957 (100)

  

CYP3A5rs776746

959

834 (87.0)

118 (12.3)

7 (0.7)

  

DPYDrs1801159

960

47 (4.9)

267 (27.8)

646 (67.3)

  

DPYDrs3918290

949

945 (99.6)

4 (0.4)

   

DPYDrs1801160

957

853 (89.1)

96 (10.0)

8 (0.9)

  

GSTA1rs3957357

938

329 (35.1)

441 (47.0)

168 (17.9)

  

GSTP1rs1695

959

118 (12.3)

452 (47.1)

389 (40.6)

  

MRP1rs1883112

956

295 (30.9)

485 (50.7)

176 (18.4)

  

MRP1rs7853758

952

701 (73.6)

231 (24.3)

20 (2.1)

  

MTHFRrs1801131

951

  

446 (46.9)

92 (9.7)

413 (43.4)

UGT2B7rs12233719

949

949 (100)

    

UGT2B7rs7662029

955

210 (22.0)

473 (49.5)

272 (28.5)

  

XPD/ERCC2rs1799793

954

412 (43.2)

429 (45.0)

113 (11.8)

  

XRCC1rs25489

954

875 (91.7)

77 (8.1)

2 (0.2)

  

XRCC3rs861534

949

357 (37.6)

441 (46.5)

151 (15.9)

  

Gene

n

TT

CC

CT

AA

TA

n (%)

n (%)

n (%)

n (%)

n (%)

ABCC2/MRP2rs17222723

951

843 (88.6)

  

2 (0.2)

106 (11.2)

ABCC2/MRP2rs2804402

935

297 (31.8)

185 (19.8)

453 (48.4)

  

CYP2B6rs8192709

927

 

846 (91.3)

87 (8.7)

  

CYP2C8rs10509681

960

740 (77.1)

12 (1.2)

208 (21.7)

  

CYP2C9rs1799853

957

15 (1.6)

712 (74.4)

230 (24)

  

CYP3A4rs4986910

959

938 (97.8)

 

21 (2.2)

  

DPYDrs1801265

960

635 (66.1)

46 (4.8)

279 (29.1)

  

FGFR4rs351855

954

88 (9.2)

461 (48.3)

405 (42.5)

  

GSTP1rs1138272

952

6 (0.6)

778 (81.7)

168 (17.7)

  

MDRI/ABCB1rs1045642

914

265 (29.0)

208 (22.8)

441 (48.2)

  

MRP1rs13058338

949

482 (50.8)

  

67 (7.1)

400 (42.1)

MRP1rs246221

956

462 (48.3)

71 (7.4)

423 (44.3)

  

MRP1rs3743527

930

13 (1.4)

562 (60.4)

355 (38.2)

  

MRP1rs4673

954

115 (12.0)

406 (42.6)

433 (45.4)

  

MTHFRrs1801133

959

121 (12.6)

401 (41.8)

437 (45.6)

  

NQO1rs1800566

958

35 (3.6)

605 (63.2)

318 (33.2)

  

UGT2B7rs7439366

955

272 (28.5)

210 (22.0)

473 (49.5)

  

UGT2B7rs7668282

954

940 (98.5)

1 (0.1)

13 (1.4)

  

Gene

n

GG

GT

TT

CC

CG

n (%)

n (%)

n (%)

n (%)

n (%)

ALDH3A1rs2228100

934

67 (7.2)

  

554 (59.3)

313 (33.5)

CYP2B6rs3745274

954

535 (56.1)

365 (38.2)

54 (5.7)

  

GPX4rs757229

940

263 (28.0)

  

212 (22.5)

465 (49.5)

MRP1rs4148350

957

847 (88.5)

105 (11.0)

5 (0.5)

  

MRP1rs45511401

960

847 (88.2)

109 (11.4)

4 (0.4)

  

UGT2B7rs3924194

954

19 (2.0%)

  

712 (74.6)

223 (23.4)

XPD/ERCC2rs13181

951

116 (12.2)

449 (47.2)

386 (40.6)

  

Gene

n

GG

GT

TT

GA

TA

n (%)

n (%)

n (%)

n (%)

n (%)

MDRI/ABCB1rs2032582

948

283 (29.9)

445 (46.9)

185 (19.5)

23 (2.4)

12 (1.3)

TYMSrs11280056

918

AAGTTA

442 (48.2)

AAGTTA.DEL

394 (42.9)

DEL

82 (8.9)